Lower numbers = closer to natural. Higher numbers = more enhanced.
Why this rating?
Ostarine is the mildest and most researched SARM, studied for muscle wasting conditions. It has the most clinical data of any SARM and is banned by WADA, confirming performance enhancement. However, effects are relatively mild, primarily muscle preservation rather than significant gains. Suppression is mild to moderate, and shorter cycles may not require PCT. Rated 5 as it represents the entry point to performance enhancement.
Overview
The most popular "beginner" SARM, used for maintenance and healing. Provides mild muscle preservation effects with a favorable safety profile compared to more potent SARMs.
Important Warnings
- •Not approved for human use
- •Banned by WADA
- •Quality varies significantly between sources
- •A frequent cause of inadvertent doping positives via contaminated "supplements"
- •Mild but real suppression: bloodwork should guide whether PCT is needed, not cycle length alone
Purpose & Use Cases
Muscle Preservation
Maintains muscle mass during caloric deficits and cutting phases.
Joint Support
Many users report improved joint comfort and healing.
Beginner SARM
Entry-level SARM for those new to performance enhancement.
Benefits
- Muscle preservation during cuts
- Joint healing and comfort
- Mild side effect profile
- Most researched SARM
- Good entry point for SARM use
- No estrogen conversion
Good to Know
The mildest common SARM: but still suppressive at real doses
Ostarine has the most human data of any SARM (Dalton/GTx POWER-era trials for muscle wasting) and is genuinely the gentlest, but controlled data still show dose-dependent drops in testosterone, LH, FSH and SHBG. Recovery is usually faster and smoother than with LGD or RAD, yet longer or higher-dose cycles can still warrant a mini-PCT. "No PCT needed" is only defensible for short, low-dose runs confirmed with bloodwork.
Lower suppression than LGD/RAD. The reason it is the beginner pick
Because Ostarine is a partial agonist with lower anabolic potency, it suppresses the axis less than the stronger SARMs, so natural testosterone tends to bounce back quicker after stopping. That trade-off (milder gains, milder shutdown) is the whole point of choosing it.
Hair-safest of the SARMs: but finasteride still would not help
Ostarine is the least likely of the common SARMs to accelerate hair loss, but if it does, the mechanism is direct androgen-receptor activation at the follicle, not DHT. Finasteride/dutasteride block DHT production and are therefore irrelevant to SARM-driven shedding.
A quality-control lottery, not a supplement
Ostarine is not approved for human use, and grey-market products vary widely in dose and purity. It is one of the most common causes of inadvertent doping positives in tested athletes because contaminated "supplements" have contained it. Buy assuming the label is unreliable.
Dosage Guidelines
| Experience Level | Dosage Range |
|---|---|
| Beginner | 10 – 15 mg/day |
| Intermediate | 15 – 20 mg/day |
| Advanced | 20 – 25 mg/day |
Often used during cutting phases for muscle preservation.
Side Effects
Mild Suppression
commonMild to moderate testosterone suppression.
Mini-PCT may be needed depending on cycle length.
Lipid Disruption
commonDose-dependent drop in HDL cholesterol (clinical trials show ~27% HDL reduction even at just 3mg/day) and reduced SHBG; more pronounced at typical recreational doses (10-25mg) than at studied clinical doses.
Omega-3s and cardiovascular exercise. Periodic lipid panel on longer runs.
General Mitigation Strategies
Mini-PCT may be needed for longer cycles. Monitor with bloodwork. One of the mildest SARMs for side effects.
Support Supplements
Ancillary supplements commonly run alongside MK-2866 to manage side effects, support the target tissue, or fill nutrient demands it creates.
Lipid support (omega-3)
Even mild SARMs nudge HDL down. Omega-3 supports triglycerides and general cardiovascular health.
- Dose
- Omega-3 2-4 g/day
- Timing
- With meals
- When
- Ostarine's lipid impact is smaller than stronger SARMs, but worth covering on longer runs.
Post Cycle Therapy (PCT)
Mini-PCT with Enclomiphene or Nolvadex may be needed for cycles over 8 weeks. Shorter cycles may not require PCT.
How It Works
Ostarine binds selectively to androgen receptors in muscle and bone. It has been studied for muscle wasting conditions and has the most clinical data of any SARM. Provides mild anabolic effects with minimal androgenic activity.
Hormonal & Androgenic Profile
Partial androgen-receptor agonist with lower anabolic potency than RAD-140/LGD. This mildness is exactly why it is the "beginner" SARM.
Does not aromatize, no AI needed. Estrogenic-looking sides are not expected from Ostarine itself.
Not a 5-alpha-reductase substrate. Ostarine is the least androgenic-on-the-scalp of the common SARMs, but any shedding it does cause is receptor-mediated and would not respond to finasteride.
Mild HDL and SHBG reduction at higher doses; the gentlest lipid profile among the common SARMs, but not zero.
Fundamentals
Reference on the practices relevant to MK-2866: how they are done and where they go wrong. Not a recommendation to use it.
Legal Status
Research chemical, not for human consumption (USA).
Legal status varies by country and changes over time. This is a general summary, not legal advice.
WADA Status
Enobosarm (Ostarine/MK-2866) is explicitly listed as a prohibited SARM under S1.2 Other Anabolic Agents.